{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:18:17Z","timestamp":1768004297032,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T00:00:00Z","timestamp":1535500800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30973061 and 81272043"],"award-info":[{"award-number":["30973061 and 81272043"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Guangdong Province","award":["2015A030313256"],"award-info":[{"award-number":["2015A030313256"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12891-018-2231-3","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T19:54:24Z","timestamp":1535572464000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Phospholipase C signaling activated by parathyroid hormone mediates the rapid osteoclastogenesis in the fracture healing of orchiectomized mice"],"prefix":"10.1186","volume":"19","author":[{"given":"Wei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guojun","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youhua","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Bringhurst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dehong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,29]]},"reference":[{"key":"2231_CR1","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/MED.0b013e328339658c","volume":"17","author":"PR Ebeling","year":"2010","unstructured":"Ebeling PR. Androgens and osteoporosis. Curr Opin Endocrinol Diabetes Obes. 2010;17:284\u201392.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2231_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00345-011-0652-9","volume":"29","author":"M Tezval","year":"2011","unstructured":"Tezval M, Serferaz G, Rack T, Kolios L, Sehmisch S, Schmelz U, et al. Effect of parathyroid hormone on hypogonadism induced bone loss of proximal femur of orchiectomized rat. World J Urol. 2011;29:529\u201334.","journal-title":"World J Urol"},{"key":"2231_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-1-59745-104-8_9","volume":"455","author":"S Blouin","year":"2008","unstructured":"Blouin S, Libouban H, Moreau MF, Chappard D. Orchidectomy models of osteoporosis. Methods Mol Biol. 2008;455:125\u201334.","journal-title":"Methods Mol Biol"},{"key":"2231_CR4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.33549\/physiolres.931003","volume":"56","author":"PD Broulik","year":"2007","unstructured":"Broulik PD, Broulikova K. Raloxifen prevents bone loss in castrated male mice. Physiol Res. 2007;56:443\u20137.","journal-title":"Physiol Res"},{"key":"2231_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0022-5347(05)68000-7","volume":"163","author":"HW Daniell","year":"2000","unstructured":"Daniell HW, Dunn SR, Ferguson DW, Lomas G, Niazi Z, Stratte PT. Progressive osteoporosis during androgen deprivation therapy for prostate cancer. J Urol. 2000;163:181\u20136.","journal-title":"J Urol"},{"key":"2231_CR6","first-page":"288","volume":"76","author":"D Goldray","year":"1993","unstructured":"Goldray D, Weisman Y, Jaccard N, Merdler C, Chen J, Matzkin H. Decreased bone density in elderly men treated with the gonadotropin-releasing hormone agonist decapeptyl (D-Trp6-GnRH). J Clin Endoctinol Metab. 1993;76:288\u201390.","journal-title":"J Clin Endoctinol Metab"},{"key":"2231_CR7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1046\/j.1365-2605.1997.00047.x","volume":"20","author":"S Boonen","year":"1997","unstructured":"Boonen S, Vanderschueren D, Geusens P, Bouillon R. Age-associated endocrine deficiencies as potential determinants of femoral neck (type II) osteoporotic fracture occurrence in elderly men. Int J Androl. 1997;20:134\u201343.","journal-title":"Int J Androl"},{"key":"2231_CR8","doi-asserted-by":"publisher","first-page":"e019291","DOI":"10.1136\/bmjopen-2017-019291","volume":"8","author":"S Lou","year":"2018","unstructured":"Lou S, Lv H, Li Z, Tang P, Wang Y. Parathyroid hormone analogues for fracture healing: protocol for a systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2018;8:e019291.","journal-title":"BMJ Open"},{"key":"2231_CR9","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.bone.2007.02.001","volume":"40","author":"D Yang","year":"2007","unstructured":"Yang D, Singh R, Divieti P, Guo J, Bouxsein ML, Bringhurst FR. Contributions of parathyroid hormone (PTH)\/PTH-related peptide receptor signaling pathways to the anabolic effect of PTH on bone. Bone. 2007;40:1453\u201361.","journal-title":"Bone"},{"key":"2231_CR10","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/00001665-200405000-00014","volume":"15","author":"TT Andreassen","year":"2004","unstructured":"Andreassen TT, Cacciafesta V. Intermittent parathyroid hormone treatment enhances guided bone regeneration in rat calvarial bone defects. J Craniofac Surg. 2004;15:424\u20137.","journal-title":"J Craniofac Surg"},{"key":"2231_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00223-011-9503-3","volume":"89","author":"B Mognetti","year":"2011","unstructured":"Mognetti B, Marino S, Barberis A, Martin AS, Bala Y, Di Carlo F, et al. Experimental stimulation of bone healing with teriparatide: histomorphometric and microhardness analysis in a mouse model of closed fracture. Calcif Tissue Int. 2011;89:163\u201371.","journal-title":"Calcif Tissue Int"},{"key":"2231_CR12","doi-asserted-by":"publisher","first-page":"e23060","DOI":"10.1371\/journal.pone.0023060","volume":"6","author":"Y Ren","year":"2011","unstructured":"Ren Y, Liu B, Feng Y, Shu L, Cao X, Karaplis A, et al. Endogenous PTH deficiency impairs fracture healing and impedes the fracture-healing efficacy of exogenous PTH(1-34). PLoS One. 2011;6:e23060.","journal-title":"PLoS One"},{"key":"2231_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/BRS.0b013e318191e687","volume":"34","author":"PF O'Loughlin","year":"2009","unstructured":"O'Loughlin PF, Cunningham ME, Bukata SV, Tomin E, Poynton AR, Doty SB, et al. Parathyroid hormone (1-34) augments spinal fusion, fusion mass volume, and fusion mass quality in a rabbit spinal fusion model. Spine (Phila Pa 1976). 2009;34:121\u201330.","journal-title":"Spine (Phila Pa 1976)"},{"key":"2231_CR14","doi-asserted-by":"publisher","first-page":"5212","DOI":"10.1210\/jc.2003-030768","volume":"88","author":"AB Hodsman","year":"2003","unstructured":"Hodsman AB, Hanley DA, Ettinger MP, Bolognese MA, Fox J, Metcalfe AJ, et al. Efficacy and safety of human parathyroid hormone-(1-84) in increasing bone mineral density in postmenopausal osteoporosis. J Clin Endocrinol Metab. 2003;88:5212\u201320.","journal-title":"J Clin Endocrinol Metab"},{"key":"2231_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1359\/jbmr.2003.18.1.18","volume":"18","author":"R Marcus","year":"2003","unstructured":"Marcus R, Wang O, Satterwhite J, Mitlak B. The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis. J Bone Miner Res. 2003;18:18\u201323.","journal-title":"J Bone Miner Res"},{"key":"2231_CR16","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1001\/archinte.165.15.1762","volume":"165","author":"MR McClung","year":"2005","unstructured":"McClung MR, San Martin J, Miller PD, Civitelli R, Bandeira F, Omizo M, et al. Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass. Arch Intern Med. 2005;165:1762\u20138.","journal-title":"Arch Intern Med"},{"key":"2231_CR17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s00774-014-0646-y","volume":"34","author":"H Tsuchie","year":"2016","unstructured":"Tsuchie H, Miyakoshi N, Kasukawa Y, Nishi T, Abe H, Segawa T, et al. The effect of teriparatide to alleviate pain and to prevent vertebral collapse after fresh osteoporotic vertebral fracture. J Bone Miner Metab. 2016;34:86\u201391.","journal-title":"J Bone Miner Metab"},{"key":"2231_CR18","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1007\/s00198-016-3651-2","volume":"27","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, Xue R, Shi N, Xue Y, Zong Y, Lin W, et al. Aggravation of spinal cord conpromise following new osteoporotic vertebral comnpression fracture prevented by teriparatide in patients with osteoporotic vertebral conpression fracture prevented by teriparatide in patients with surgical contraindications. Osteoporos Int. 2016;27:3309\u201317.","journal-title":"Osteoporos Int"},{"key":"2231_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-1119(01)00798-3","volume":"282","author":"JT Swarthout","year":"2002","unstructured":"Swarthout JT, D'Alonzo RC, Selvamurugan N, Partridge NC. Parathyroid hormone -dependent signaling pathways regulating genes in bone cells. Gene. 2002;282:1\u201317.","journal-title":"Gene"},{"key":"2231_CR20","first-page":"3757","volume":"84","author":"R Brommage","year":"1999","unstructured":"Brommage R, Hotchkiss CE, Lees CJ, Stancill MW, Hock JM, Jerome CP. Daily treatment with human recombinant parathyroid hormone-(1-34), LY333334, for 1 year increases bone mass in ovariectomized monkeys. J Clin Endocrinol Metab. 1999;84:3757\u201363.","journal-title":"J Clin Endocrinol Metab"},{"key":"2231_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00223-010-9360-5","volume":"87","author":"M Ellegaard","year":"2010","unstructured":"Ellegaard M, Jorgensen NR, Schwarz P. Parathyroid hormone and bone healing. Calcif Tissue Int. 2010;87:1\u201313.","journal-title":"Calcif Tissue Int"},{"key":"2231_CR22","first-page":"731","volume":"87","author":"YM Alkhiary","year":"2005","unstructured":"Alkhiary YM, Gerstenfeld LC, Krall E, Westmore M, Sato M, Mitlak BH, et al. Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34). J Bone Joint Surg Am. 2005;87:731\u201341.","journal-title":"J Bone Joint Surg Am"},{"key":"2231_CR23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/jcb.21816","volume":"105","author":"LA Kaback","year":"2008","unstructured":"Kaback LA, Soung do Y, Naik A, Geneau G, Schwarz EM, Rosier RN, et al. Teriparatide (1-34 human PTH) regulation of osterix during fracture repair. J Cell Biochem. 2008;105:219\u201326.","journal-title":"J Cell Biochem"},{"key":"2231_CR24","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1359\/jbmr.2002.17.11.2038","volume":"17","author":"A Nakajima","year":"2002","unstructured":"Nakajima A, Shimoji N, Shiomi K, Shimizu S, Moriya H, Einhorn TA, et al. Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34). J Bone Miner Res. 2002;17:2038\u201347.","journal-title":"J Bone Miner Res"},{"key":"2231_CR25","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.bone.2012.09.039","volume":"52","author":"X Yang","year":"2012","unstructured":"Yang X, Muthukumaran P, DasDe S, Teoh SH, Choi H, Lim SK, et al. Positive alterations of viscoelastic and geometric properties in ovariectomized rat femurs with concurrent administration of ibandronate and PTH. Bone. 2012;52:308\u201317.","journal-title":"Bone"},{"key":"2231_CR26","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.bone.2005.10.009","volume":"38","author":"D Yang","year":"2006","unstructured":"Yang D, Guo J, Divieti P, Bringhurst FR. Parathyroid hormone activates PKC-delta and regulates osteoblastic differentiation via a PLC-independent pathway. Bone. 2006;38:485\u201396.","journal-title":"Bone"},{"key":"2231_CR27","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.12659\/MSM.903699","volume":"23","author":"G Tong","year":"2017","unstructured":"Tong G, Meng Y, Hao S, Hu S, He Y, Yan W, et al. Parathyroid hormone activates phospholipase C (PLC)-independent protein kinase C signaling pathway via protein kinase a (PKA)-dependent mechanism: a new defined signaling route would induce alternative consideration to previous conceptions. Med Sci Monit. 2017;23:1896\u2013906.","journal-title":"Med Sci Monit"},{"key":"2231_CR28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S1534-5807(02)00218-6","volume":"3","author":"J Guo","year":"2002","unstructured":"Guo J, Chung UI, Kondo H, Bringhurst FR, Kronenberg HM. The PTH\/PTHrP receptor can delay chondrocyte hypertrophy in vivo without activating phospholipase C. Dev Cell. 2002;3:183\u201394.","journal-title":"Dev Cell"},{"key":"2231_CR29","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1210\/en.2009-1494","volume":"151","author":"J Guo","year":"2010","unstructured":"Guo J, Liu M, Yang D, Bouxsein ML, Thomas CC, Schipani E, et al. Phospholipase C signaling via the parathyroid hormone (PTH)\/PTH-related peptide receptor is essential for normal bone responses to PTH. Endocrinology. 2010;151:3502\u201313.","journal-title":"Endocrinology"},{"key":"2231_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11657-017-0324-5","volume":"12","author":"J Compston","year":"2017","unstructured":"Compston J, Cooper A, Cooper C, Gittoes N, Gregson C, Harvey N, et al. UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteopos. 2017;12:43.","journal-title":"Arch Osteopos"},{"key":"2231_CR31","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1210\/en.2007-0826","volume":"149","author":"D Yang","year":"2008","unstructured":"Yang D, Guo J, Divieti P, Shioda T, Bringhurst FR. CBP\/p300-interacting protein CITED1 modulates parathyroid hormone regulation of osteoblastic differentiation. Endocrinology. 2008;149:1728\u201335.","journal-title":"Endocrinology"},{"key":"2231_CR32","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1007\/s00198-005-1876-6","volume":"16","author":"Y Gabet","year":"2005","unstructured":"Gabet Y, Kohavi D, Muller R, Chorev M, Bab I. Intermittently administered parathyroid hormone 1-34 reverses bone loss and structural impairment in orchiectomized adult rats. Osteoporos Int. 2005;16:1436\u201343.","journal-title":"Osteoporos Int"},{"key":"2231_CR33","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1152\/japplphysiol.00498.2002","volume":"94","author":"J Wu","year":"2003","unstructured":"Wu J, Wang XX, Chiba H, Higuchi M, Takasaki M, Ohta A, et al. Combined intervention of exercise and genistein prevented androgen deficiency-induced bone loss in mice. J Appl Physiol. 2003;94:335\u20133342.","journal-title":"J Appl Physiol"},{"key":"2231_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1530\/JOE-10-0353","volume":"209","author":"M Komrakova","year":"2011","unstructured":"Komrakova M, Krischek C, Wicke M, Sehmisch S, Tezval M, Rohrberg M, et al. Influence of intermittent administration of parathyroid hormone on muscle tissue and bone healing in orchiectomized rats or controls. J Endocrinol. 2011;209:9\u201319.","journal-title":"J Endocrinol"},{"key":"2231_CR35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jor.1100020115","volume":"2","author":"F Bonnarens","year":"1984","unstructured":"Bonnarens F, Einhorn TA. Production of a standard closed fracture in laboratory animal bone. J Orthop Res. 1984;2:97\u2013101.","journal-title":"J Orthop Res"},{"key":"2231_CR36","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S8756-3282(01)00406-9","volume":"28","author":"H Uusitalo","year":"2001","unstructured":"Uusitalo H, Rantakokko J, Ahonen M, Jamsa T, Tuukkanen J, KaHari V, et al. A metaphyseal defect model of the femur for studies of murine bone healing. Bone. 2001;28:423\u20139.","journal-title":"Bone"},{"key":"2231_CR37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1359\/JBMR.0301226","volume":"19","author":"JC Huang","year":"2004","unstructured":"Huang JC, Sakata T, Pfleger LL, Bencsik M, Halloran BP, Bikle DD, et al. PTH differentially regulates expression of RANKL and OPG. J Bone Miner Res. 2004;19:235\u201344.","journal-title":"J Bone Miner Res"},{"key":"2231_CR38","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1210\/endo.143.2.8614","volume":"143","author":"BY Liu","year":"2002","unstructured":"Liu BY, Wu PW, Bringhurst FR, Wang JT. Estrogen inhibition of PTH-stimulated osteoclast formation and attachment in vitro: involvement of both PKA and PKC. Endocrinology. 2002;143:627\u201335.","journal-title":"Endocrinology"},{"key":"2231_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2302\/kjm.52.1","volume":"52","author":"T Miyamoto","year":"2003","unstructured":"Miyamoto T, Suda T. Differentiation and function of osteoclasts. Keio J Med. 2003;52:1\u20137.","journal-title":"Keio J Med"},{"key":"2231_CR40","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1172\/JCI28775","volume":"116","author":"D Mao","year":"2006","unstructured":"Mao D, Epple H, Uthgenannt B, Novack DV, Faccio R. PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2. J Clin Invest. 2006;116:2869\u201379.","journal-title":"J Clin Invest"},{"key":"2231_CR41","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1359\/jbmr.2002.17.9.1667","volume":"17","author":"H Kondo","year":"2002","unstructured":"Kondo H, Guo J, Bringhurst FR. Cyclic adenosine monophosphate\/protein kinase A mediates parathyroid hormone\/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells. J Bone Miner Res. 2002;17:1667\u201379.","journal-title":"J Bone Miner Res"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-018-2231-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12891-018-2231-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-018-2231-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T20:35:23Z","timestamp":1661891723000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-018-2231-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,29]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2231"],"URL":"https:\/\/doi.org\/10.1186\/s12891-018-2231-3","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,29]]},"assertion":[{"value":"11 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal procedures were performed under the approval and guidance of the Animal Care and Use Committee of Southern Medical University. The approve NO. is NFYY-2017-07.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"311"}}